Human nerve growth factor by recombinant technology

The beta-subunit of human nerve growth factor (betaNGF) is prepared in essentially pure form in commercially useful quantities using recombinant DNA technology. The nucleotide sequence and vectors encoding human betaNGF and host cells transformed with the vectors are also provided. The betaNGF which...

Full description

Saved in:
Bibliographic Details
Main Authors GRAY ALANE M, ULLRICH AXEL
Format Patent
LanguageEnglish
Published 15.10.2013
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The beta-subunit of human nerve growth factor (betaNGF) is prepared in essentially pure form in commercially useful quantities using recombinant DNA technology. The nucleotide sequence and vectors encoding human betaNGF and host cells transformed with the vectors are also provided. The betaNGF which the invention provides is useful, for example, in treating nerve damage.
Bibliography:Application Number: US19950417188